You are here : Home / Annual Results / TORRENT PHARMACEUTICALS LTD

TORRENT PHARMACEUTICALS Financials & Share Price [BOM: 500420|NSE : TORNTPHARM]

The Revenues of TORRENT PHARMACEUTICALS has increased by 0.83% YoY. The Earnings Per Share (EPS) of TORRENT PHARMACEUTICALS has increased by 22.16 % YoY.
Y-o-Y REVENUES OPERATING MARGIN PROFIT AFTER TAX EPS ROCE Details👇

TORRENT PHARMACEUTICALS Share Price vs Sensex

Current Share Price: ₹3,100.3, Current MarketCap: ₹52,456.2 Cr, Updated EOD on : Sep 24,2021
Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

0.2%

1.5%

7.4%

SENSEX

2.7%

7.3%

54.2%

What is the Intrinsic Value of TORRENT PHARMACEUTICALS ?

TORRENT PHARMACEUTICALS Last 5 Annual Results
[BOM: 500420|NSE : TORNTPHARM]

ConsolidatedMar2021
Mar2020
Mar2019
Mar2018
Mar2017
Revenues ₹8,005 Cr₹7,939 Cr₹7,673 Cr₹5,950 Cr₹5,816 Cr
Expenses ₹5,538 Cr₹5,769 Cr₹5,696 Cr₹4,601 Cr₹4,438 Cr
Operating Profit (Excl OI) ₹2,467 Cr₹2,170 Cr₹1,976 Cr₹1,349 Cr₹1,377 Cr
Other Income ₹76 Cr₹121 Cr₹64 Cr₹299 Cr₹223 Cr
Interest ₹358 Cr₹451 Cr₹504 Cr₹308 Cr₹206 Cr
Depreciation ₹658 Cr₹654 Cr₹618 Cr₹409 Cr₹307 Cr
Profit Before Tax ₹1,526 Cr₹1,187 Cr₹562 Cr₹931 Cr₹1,088 Cr
Profit After Tax ₹1,252 Cr₹1,025 Cr₹436 Cr₹678 Cr₹934 Cr
Consolidated Net Profit ₹1,252 Cr₹1,025 Cr₹436 Cr₹678 Cr₹934 Cr
Earnings Per Share (Rs)₹73.97₹60.55₹25.78₹40.07₹55.16
PAT Margin (%)8.416.853.006.0215.94
ROE(%)23.4921.479.3415.1223.80
ROCE(%)17.6315.289.7513.8120.36
Total Debt/Equity(x)0.841.211.281.400.58
Key Financials
Market Cap : ₹ 52,456.2 Cr
Revenue (TTM) : ₹ 8,083.0 Cr
Net Profit(TTM) : ₹ 1,261.0 Cr
EPS (TTM) : ₹ 74.5
P/E (TTM) : 41.6

Check out Industry Peers

Peers & Returns1W1M1Y
TORRENT PHARMACEUTICALS 0.2% 1.5% 7.4%
SUN PHARMACEUTICAL INDUSTRIES -0.1% -0.3% 47.1%
DIVIS LABORATORIES 1.7% 7.3% 53.8%
DR REDDYS LABORATORIES -1.9% 4.5% -9%
CIPLA 1.5% 5.5% 19.6%
GLAND PHARMA -1.6% 2.6% NA
PIRAMAL ENTERPRISES 5.6% 6.6% 95.6%
CADILA HEALTHCARE 1.6% 3.3% 37.2%
ALKEM LABORATORIES 5.7% 4.8% 38.4%

What is the Fundamental Analysis of TORRENT PHARMACEUTICALS ?

TORRENT PHARMACEUTICALS Revenues
[BOM: 500420|NSE : TORNTPHARM]

Revenues
Y-o-Y

0.83 %

5 Yr CAGR

8.31 %

Years Revenues % Change
Mar2021 ₹8,005 Cr
0.83
Mar2020 ₹7,939 Cr
3.47
Mar2019 ₹7,673 Cr
28.96
Mar2018 ₹5,950 Cr
2.31
Mar2017 ₹5,816 Cr -
What is the Valuation of TORRENT PHARMACEUTICALS ?

TORRENT PHARMACEUTICALS Operating Profit
[BOM: 500420|NSE : TORNTPHARM]

Operating Profit
Y-o-Y

13.65 %

5 Yr CAGR

15.68 %

Years Operating Profit % Change
Mar2021 ₹2,467 Cr
13.65
Mar2020 ₹2,170 Cr
9.81
Mar2019 ₹1,976 Cr
46.49
Mar2018 ₹1,349 Cr
-2.03
Mar2017 ₹1,377 Cr -
Operating Margins
Y-o-Y

12.69 %

5 Yr CAGR

6.80 %

Years Operating Margin% % Change
Mar2021 30.81%
12.69
Mar2020 27.34%
6.13
Mar2019 25.76%
13.58
Mar2018 22.68%
-4.22
Mar2017 23.68% -

TORRENT PHARMACEUTICALS Profit After Tax
[BOM: 500420|NSE : TORNTPHARM]

Profit After Tax(PAT)
Y-o-Y

22.17 %

5 Yr CAGR

7.61 %

Years Profit After Tax % Change
Mar2021 ₹1,252 Cr
22.17
Mar2020 ₹1,025 Cr
134.88
Mar2019 ₹436 Cr
-35.66
Mar2018 ₹678 Cr
-27.36
Mar2017 ₹934 Cr -
PAT Margins
Y-o-Y

22.77 %

5 Yr CAGR

-14.77 %

Years PAT Margin(%) % Change
Mar2021 8.41 %
22.77
Mar2020 6.85 %
128.33
Mar2019 3 %
-50.17
Mar2018 6.02 %
-62.23
Mar2017 15.94 % -

TORRENT PHARMACEUTICALS Earnings Per Share (EPS)
[BOM: 500420|NSE : TORNTPHARM]

EPS
Y-o-Y

22.16 %

5 Yr CAGR

7.61 %

Years EPS % Change
Mar2021 ₹74
22.16
Mar2020 ₹61
134.87
Mar2019 ₹26
-35.66
Mar2018 ₹40
-27.36
Mar2017 ₹55 -

TORRENT PHARMACEUTICALS Return on Capital Employed (ROCE)
[BOM: 500420|NSE : TORNTPHARM]

ROCE
Y-o-Y

15.38 %

5 Yr CAGR

-3.54 %

Years ROCE % Change
Mar2021 17.63%
15.38
Mar2020 15.28%
56.72
Mar2019 9.75%
-29.40
Mar2018 13.81%
-32.17
Mar2017 20.36% -
What is the Valuation of TORRENT PHARMACEUTICALS ?

TORRENT PHARMACEUTICALS related INDICES

BSE Indices1W1M1Y
S&P BSE MOMENTUM 2.8% 7.2% 41.8%
S&P BSE LARGE MIDCAP 2.5% 7.6% 56.6%
S&P BSE 100 2.5% 7.4% 55.5%
S&P BSE CARBONEX 2.5% 7.2% 54.9%
S&P BSE 250 LARGEMIDCAP 2.5% 7.6% 57.8%
S&P BSE 200 2.5% 7.6% 57.5%
S&P BSE 100 LARGECAP TMC 2.5% 7.4% 55.3%
S&P BSE 500 2.5% 7.7% 59.1%
S&P BSE ALLCAP 2.4% 7.7% 60.1%
S&P BSE MID CAP 2.4% 9.8% 69.4%
S&P BSE MIDSMALLCAP 2.2% 8.8% 76.8%
S&P BSE SENSEX NEXT 50 2.1% 8.9% 59.4%
S&P BSE MIDCAP SELECT INDEX 1.2% 7.7% 63.3%
S&P BSE HEALTHCARE 0.4% 1.9% 30.3%
NSE Indices1W1M1Y
NIFTY 200 2.5% 7.8% 57.6%
NIFTY LARGE MIDCAP 250 2.5% 8.3% 63.2%
NIFTY 100 2.5% 7.5% 55.4%
NIFTY 500 2.5% 7.8% 59.1%
NIFTY500 MULTICAP 50:25:25 2.4% 8.1% NA
NIFTY ALPHA LOW-VOLATILTY 30 2.1% 8.2% 47.8%
NIFTY NEXT 50 1.7% 8.3% 57.7%
NIFTY PHARMA 1.4% 3.3% 16.7%
NIFTY HEALTHCARE 0.6% 1.5% NA

FAQ [Frequently Asked Questions]


What is the share price of TORRENT PHARMACEUTICALS ?

The current share price of TORRENT PHARMACEUTICALS is ₹ 3,100.3.

What are the share price returns of TORRENT PHARMACEUTICALS ?

The share price returns of TORRENT PHARMACEUTICALS are as under:
1 Week : 0.2%
1 Month : 1.5%
1 Year : 7.4%

Check out Intrinsic Value of Industry Peers
Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES LTD
Intrinsic Value of DIVIS LABORATORIES LTD
Intrinsic Value of DR REDDYS LABORATORIES LTD
Intrinsic Value of CIPLA LTD
Intrinsic Value of GLAND PHARMA LTD
Intrinsic Value of PIRAMAL ENTERPRISES LTD
Intrinsic Value of CADILA HEALTHCARE LTD
Intrinsic Value of TORRENT PHARMACEUTICALS LTD
Intrinsic Value of ALKEM LABORATORIES LTD
Intrinsic Value of LUPIN LTD
Intrinsic Value of AUROBINDO PHARMA LTD
Intrinsic Value of BIOCON LTD
Intrinsic Value of ABBOTT INDIA LTD
Intrinsic Value of LAURUS LABS LTD
Intrinsic Value of IPCA LABORATORIES LTD
Check out Quarterly Results of Industry Peers
Quarterly Results of SUN PHARMACEUTICAL INDUSTRIES LTD
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of GLAND PHARMA LTD
Quarterly Results of PIRAMAL ENTERPRISES LTD
Quarterly Results of CADILA HEALTHCARE LTD
Quarterly Results of TORRENT PHARMACEUTICALS LTD
Quarterly Results of ALKEM LABORATORIES LTD
Quarterly Results of LUPIN LTD
Quarterly Results of AUROBINDO PHARMA LTD
Quarterly Results of BIOCON LTD
Quarterly Results of ABBOTT INDIA LTD
Quarterly Results of LAURUS LABS LTD
Quarterly Results of IPCA LABORATORIES LTD

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of SUN PHARMACEUTICAL INDUSTRIES LTD
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD
Market Cap of PIRAMAL ENTERPRISES LTD
Market Cap of CADILA HEALTHCARE LTD
Market Cap of TORRENT PHARMACEUTICALS LTD
Market Cap of ALKEM LABORATORIES LTD
Market Cap of LUPIN LTD
Market Cap of AUROBINDO PHARMA LTD
Market Cap of BIOCON LTD
Market Cap of ABBOTT INDIA LTD
Market Cap of LAURUS LABS LTD
Market Cap of IPCA LABORATORIES LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z